Clinical Trials · NCT02592083
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Thomas Hatschek
- Enrollment
- 10
- Start date
- Oct 2015
- Locations
- 1 site, Sweden
- Primary endpoint
- Clinical and Radiological Response